Displaying drugs 51 - 75 of 1617 in total
NGGT-002
NGGT-002 is a recombinant adeno-associated virus serotype 8 vector encoding human phenylalanine hydroxylase (PAH).
Investigational
Matched Name: … NGGT-002 …
Matched Description: … NGGT-002 is a recombinant adeno-associated virus serotype 8 vector encoding human phenylalanine hydroxylase …
Matched Description: … NGGT-002 is a recombinant adeno-associated virus serotype 8 vector encoding human phenylalanine hydroxylase …
AMGN-0007
Recombinant osteoprotegerin (AMGN-0007) is a recombinant OPG construct developed as a potential therapeutic agent in the treatment of bone disease.
Investigational
Matched Name: … AMGN-0007 …
Matched Description: … Recombinant osteoprotegerin (AMGN-0007) is a recombinant OPG construct developed as a potential therapeutic …
Matched Description: … Recombinant osteoprotegerin (AMGN-0007) is a recombinant OPG construct developed as a potential therapeutic …
GLPG-0187
GLPG0187 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Name: … GLPG-0187 …
GLPG-0492
Glpg0492 is under investigation in clinical trial NCT01130818 (First-in-Human Single Ascending Dose of GLPG0492).
Investigational
Matched Name: … GLPG-0492 …
IMCY-0141
IMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen, designed to stop the progression of multiple sclerosis (MS) and the destruction of the myelin sheath protecting the nerves.
Investigational
Matched Name: … IMCY-0141 …
Matched Description: … IMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen …
Matched Description: … IMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen …
PF-04991532
PF-04991532 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2, and Glucose Metabolism Disorders.
Investigational
Matched Name: … PF-04991532 …
Matched Description: … PF-04991532 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 Diabetes …
Matched Description: … PF-04991532 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 Diabetes …
PF-03463275
PF-03463275 has been used in trials studying the treatment of Schizophrenia and Cognitive Impairments Associated With Schizophrenia.
Investigational
Matched Name: … PF-03463275 …
Matched Description: … PF-03463275 has been used in trials studying the treatment of Schizophrenia and Cognitive Impairments …
Matched Description: … PF-03463275 has been used in trials studying the treatment of Schizophrenia and Cognitive Impairments …
PF-04457845
PF-04457845 is under investigation in Fear Conditioning. PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence.
Investigational
Matched Name: … PF-04457845 …
Matched Description: … PF-04457845 is under investigation in Fear Conditioning. ... PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence. …
Matched Description: … PF-04457845 is under investigation in Fear Conditioning. ... PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence. …
PF-05175157
PF-05175157 has been used in trials studying the basic science and treatment of Acne Vulgaris, Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus Type 2, and Diabetes Mellitus, Type 2, among others.
Investigational
Matched Name: … PF-05175157 …
Matched Description: … PF-05175157 has been used in trials studying the basic science and treatment of Acne Vulgaris, Diabetes …
Matched Description: … PF-05175157 has been used in trials studying the basic science and treatment of Acne Vulgaris, Diabetes …
PF-03654746
PF-03654746 has been investigated for the treatment of Narcolepsy, Schizophrenia, Tourette's Syndrome, and Excessive Daytime Sleepiness.
Investigational
Matched Name: … PF-03654746 …
Matched Description: … PF-03654746 has been investigated for the treatment of Narcolepsy, Schizophrenia, Tourette's Syndrome …
Matched Description: … PF-03654746 has been investigated for the treatment of Narcolepsy, Schizophrenia, Tourette's Syndrome …
PF-03654764
PF-03654764 has been used in trials studying the basic science and treatment of Allergic Rhinitis.
Investigational
Matched Name: … PF-03654764 …
Matched Description: … PF-03654764 has been used in trials studying the basic science and treatment of Allergic Rhinitis. …
Matched Description: … PF-03654764 has been used in trials studying the basic science and treatment of Allergic Rhinitis. …
Pf-04531083
Pf-04531083 has been investigated for the treatment of Pain and Chronic Pain.
Investigational
Matched Name: … Pf-04531083 …
Matched Description: … Pf-04531083 has been investigated for the treatment of Pain and Chronic Pain. …
Matched Description: … Pf-04531083 has been investigated for the treatment of Pain and Chronic Pain. …
PF-00217830
PF-00217830 has been used in trials studying the treatment of Schizophrenia.
Investigational
Matched Name: … PF-00217830 …
Matched Description: … PF-00217830 has been used in trials studying the treatment of Schizophrenia. …
Matched Description: … PF-00217830 has been used in trials studying the treatment of Schizophrenia. …
PF-05180999
PF-05180999 is under investigation in clinical trial NCT01530529 (A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999).
Investigational
Matched Name: … PF-05180999 …
Matched Description: … of a Modified-Release Formulation of PF-05180999). ... PF-05180999 is under investigation in clinical trial NCT01530529 (A Study to Assess the Relative Bioavailability …
Matched Description: … of a Modified-Release Formulation of PF-05180999). ... PF-05180999 is under investigation in clinical trial NCT01530529 (A Study to Assess the Relative Bioavailability …
AK106-001616
AK106-001616 is under investigation in clinical trial NCT01285752 (A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)).
Investigational
Matched Name: … AK106-001616 …
Matched Description: … AK106-001616 is under investigation in clinical trial NCT01285752 (A Study of AK106-001616 in Patients …
Matched Description: … AK106-001616 is under investigation in clinical trial NCT01285752 (A Study of AK106-001616 in Patients …
U-0126
U-0126 is a direct inhibitor of the mitogen-activated protein-kinase kinase family members, MEK-1 and MEK-2.
Investigational
Matched Name: … U-0126 …
Matched Description: … U-0126 is a direct inhibitor of the mitogen-activated protein-kinase kinase family members, MEK-1 and …
Matched Salts name: … U-0126-EtOH …
Matched Description: … U-0126 is a direct inhibitor of the mitogen-activated protein-kinase kinase family members, MEK-1 and …
Matched Salts name: … U-0126-EtOH …
ALMB-0168
ALMB-0168 is a humanized connexin 43 (Cx43) monoclonal antibody being investigated for osteosarcoma.
Investigational
Matched Synonyms: … ALMB 0168 …
Matched Name: … ALMB-0168 …
Matched Description: … ALMB-0168 is a humanized connexin 43 (Cx43) monoclonal antibody being investigated for osteosarcoma. …
Matched Name: … ALMB-0168 …
Matched Description: … ALMB-0168 is a humanized connexin 43 (Cx43) monoclonal antibody being investigated for osteosarcoma. …
Displaying drugs 51 - 75 of 1617 in total